• Stelara 90 mg solution for injection in pre-filled syringe

  Form: solution for injection in a pre-filled syringe

  Active substance	Dosage
  USTEKINUMAB	90 mg

  ATC: L04A L04AC L04AC05

• Symtuza 800 mg/150 mg/200 mg/10 mg film-coated tablets

  Form: tablets

  Active substance	Dosage
  DARUNAVIR ETHANOLATE	867 mg
  COBICISTAT	150 mg
  EMTRICITABINE	200 mg
  TENOFOVIR ALAFENAMIDE FUMARATE	11,2 mg

  ATC: J05A J05AR J05AR22

• Talvey 2 mg/ml solution for injection

  Form: solution for injection

  Active substance	Dosage
  TALQUETAMAB	3 mg

  ATC: L01F L01FX L01FX29

• Talvey 40 mg/ml solution for injection

  Form: solution for injection

  Active substance	Dosage
  TALQUETAMAB	40 mg

  ATC: L01F L01FX L01FX29

• Tecvayli 10 mg/ml solution for injection

  Form: solution for injection

  Active substance	Dosage
  TECLISTAMAB	30 mg

  ATC: L01F L01FX L01FX24

• Tecvayli 90 mg/ml solution for injection

  Form: solution for injection

  Active substance	Dosage
  TECLISTAMAB	153 mg

  ATC: L01F L01FX L01FX24

• Tremfya 100 mg OnePress solution for injection in pre-filled pen

  Form: solution for injection in pre-filled pen

  Active substance	Dosage
  GUSELKUMAB	100 mg

  ATC: L04A L04AC L04AC16

• Tremfya 100 mg solution for injection in pre-filled syringe

  Form: solution for injection in a pre-filled syringe

  Active substance	Dosage
  GUSELKUMAB	105 mg

  ATC: L04A L04AC L04AC16

• Tremfya 200 mg concentrate for solution for infusion

  Form: solution for infusion, concentrate

  Active substance	Dosage
  GUSELKUMAB	200 mg

  ATC: L04A L04AC L04AC16

• Tremfya 200 mg solution for injection in pre-filled pen

  Form: solution for injection

  Active substance	Dosage
  GUSELKUMAB	200 mg

  ATC: L04A L04AC L04AC16

• Trevicta 175 mg prolonged-release injectable suspension

  Form: suspension for injection, prolonged release

  Active substance	Dosage
  PALIPERIDONE PALMITATE	175 mg

  ATC: N05A N05AX N05AX13

• Trevicta 263 mg prolonged-release injectable suspension

  Form: suspension for injection, prolonged release

  Active substance	Dosage
  PALIPERIDONE PALMITATE	410 mg

  ATC: N05A N05AX N05AX13

• Trevicta 350 mg prolonged-release injectable suspension

  Form: suspension for injection, prolonged release

  Active substance	Dosage
  PALIPERIDONE PALMITATE	546 mg

  ATC: N05A N05AX N05AX13

• Trevicta 525 mg prolonged-release injectable suspension

  Form: suspension for injection, prolonged release

  Active substance	Dosage
  PALIPERIDONE PALMITATE	819 mg

  ATC: N05A N05AX N05AX13

• Uptravi 1000 mcg film-coated tablets

  Form: tablets, film-coated

  Active substance	Dosage
  SELEXIPAG	1,000 µg

  ATC: B01A B01AC B01AC27

• Uptravi 1200 mcg film-coated tablets

  Form: tablets, film-coated

  Active substance	Dosage
  SELEXIPAG	1,200 µg

  ATC: B01A B01AC B01AC27

• Uptravi 1400 mcg film-coated tablets

  Form: tablets, film-coated

  Active substance	Dosage
  SELEXIPAG	1,400 µg

  ATC: B01A B01AC B01AC27

• Uptravi 1600 mcg film-coated tablets

  Form: tablets, film-coated

  Active substance	Dosage
  SELEXIPAG	1,600 µg

  ATC: B01A B01AC B01AC27

• Uptravi 200 mcg film-coated tablets

  Form: tablets, film-coated

  Active substance	Dosage
  SELEXIPAG	200 µg

  ATC: B01A B01AC B01AC27

• Uptravi 400 mcg film-coated tablets

  Form: tablets, film-coated

  Active substance	Dosage
  SELEXIPAG	400 µg

  ATC: B01A B01AC B01AC27

• Uptravi 600 mcg film-coated tablets

  Form: tablets, film-coated

  Active substance	Dosage
  SELEXIPAG	600 µg

  ATC: B01A B01AC B01AC27

• Uptravi 800 mcg film-coated tablets

  Form: tablets, film-coated

  Active substance	Dosage
  SELEXIPAG	800 µg

  ATC: B01A B01AC B01AC27

• Velcade 3.5 mg, powder for solution for injection

  Form: powder for solution for injection

  Active substance	Dosage
  BORTEZOMIB	3,5 mg

  ATC: L01X L01XG L01XG01

• Veletri 0.5 mg powder and solvent for solution for infusion

  Form: powder and solvent for solution for infusion

  Active substance	Dosage
  EPOPROSTENOL SODIUM	0,531 mg

  ATC: B01A B01AC B01AC09

• Veletri 1.5 mg powder and solvent for solution for infusion

  Form: powder and solvent for solution for infusion

  Active substance	Dosage
  EPOPROSTENOL SODIUM	1,593 mg

  ATC: B01A B01AC B01AC09

• Vokanamet 150 mg/1000 mg film-coated tablets

  Form: tablets, film-coated

  Active substance	Dosage
  METFORMIN HYDROCHLORIDE	1000 mg
  CANAGLIFLOZIN	153 mg

  ATC: A10B A10BD A10BD16

• Vokanamet 150 mg/850 mg film-coated tablets

  Form: tablets, film-coated

  Active substance	Dosage
  METFORMIN HYDROCHLORIDE	850 mg
  CANAGLIFLOZIN	153 mg

  ATC: A10B A10BD A10BD16

• Vokanamet 50 mg/1000 mg film-coated tablets

  Form: tablets, film-coated

  Active substance	Dosage
  CANAGLIFLOZIN	51 mg
  METFORMIN HYDROCHLORIDE	1000 mg

  ATC: A10B A10BD A10BD16

• Vokanamet 50 mg/850 mg film-coated tablets

  Form: tablets, film-coated

  Active substance	Dosage
  METFORMIN HYDROCHLORIDE	850 mg
  CANAGLIFLOZIN	51 mg

  ATC: A10B A10BD A10BD16

• Xeplion 100 mg prolonged-release injectable suspension

  Form: suspension for injection, in pre-filled syringe

  Active substance	Dosage
  PALIPERIDONE PALMITATE	100 mg

  ATC: N05A N05AX N05AX13

• Xeplion 150 mg prolonged-release injectable suspension

  Form: suspension for injection, in pre-filled syringe

  Active substance	Dosage
  PALIPERIDONE PALMITATE	100 mg

  ATC: N05A N05AX N05AX13

• Xeplion 50 mg prolonged-release injectable suspension

  Form: suspension for injection, in pre-filled syringe

  Active substance	Dosage
  PALIPERIDONE PALMITATE	50 mg

  ATC: N05A N05AX N05AX13

• Xeplion 75 mg prolonged-release injectable suspension

  Form: suspension for injection, in pre-filled syringe

  Active substance	Dosage
  PALIPERIDONE PALMITATE	75 mg

  ATC: N05A N05AX N05AX13

• Yuvanci 10 mg/20 mg film-coated tablets

  Form: tablets, film-coated

  Active substance	Dosage
  MACITENTAN	10 mg
  TADALAFIL	20 mg

  ATC: C02K C02KX C02KX54

• Yuvanci 10 mg/40 mg film-coated tablets

  Form: tablets, film-coated

  Active substance	Dosage
  MACITENTAN	10 mg
  TADALAFIL	40 mg

  ATC: C02K C02KX C02KX54

• Zavesca 100 mg hard capsules

  Form: capsules, hard

  Active substance	Dosage
  MIGLUSTAT	100 mg

  ATC: A16A A16AX A16AX06

• Zytiga 500 mg film-coated tablets

  Form: tablets, film-coated

  Active substance	Dosage
  ABIRATERONE ACETATE	500 mg

  ATC: L02B L02BX L02BX03